Katherine Ruzhansky

1.5k total citations
13 papers, 300 citations indexed

About

Katherine Ruzhansky is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Katherine Ruzhansky has authored 13 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 2 papers in Cellular and Molecular Neuroscience and 1 paper in Molecular Biology. Recurrent topics in Katherine Ruzhansky's work include Myasthenia Gravis and Thymoma (9 papers), Peripheral Neuropathies and Disorders (6 papers) and Parkinson's Disease and Spinal Disorders (5 papers). Katherine Ruzhansky is often cited by papers focused on Myasthenia Gravis and Thymoma (9 papers), Peripheral Neuropathies and Disorders (6 papers) and Parkinson's Disease and Spinal Disorders (5 papers). Katherine Ruzhansky collaborates with scholars based in United States, Japan and Switzerland. Katherine Ruzhansky's co-authors include Thomas H. Brannagan, Rebecca Traub, James F. Howard, Richard J. Nowak, Michael K. Hehir, Ted M. Burns, Diantha B. Howard, Melissa Fellman, Amy Visser and Michael Benatar and has published in prestigious journals such as PLoS ONE, Neurology and Muscle & Nerve.

In The Last Decade

Katherine Ruzhansky

12 papers receiving 291 citations

Peers

Katherine Ruzhansky

NEURO

PHYSI

CMN

SURGE

Piotr Szczudlik Poland

J Palace Italy

Fu Liong Hiew Malaysia

Naoya Minami Japan

A. Gordon Smith United States

Anna De Rosa Italy

Giovanna S. Manzano United States

Enrique Gómez‐Figueroa Mexico

Asuka Nakajima Japan

Hans-Hilmar Goebel Germany

Piotr Szczudlik Poland

Katherine Ruzhansky

183 ×0.7

NEURO

53 ×0.7

7 ×0.2

PHYSI

15 ×0.5

CMN

17 ×0.9

SURGE

Citations per year, relative to Katherine Ruzhansky Katherine Ruzhansky (= 1×) peers Piotr Szczudlik

Countries citing papers authored by Katherine Ruzhansky

Since Specialization

Citations

This map shows the geographic impact of Katherine Ruzhansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Ruzhansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Ruzhansky more than expected).

Fields of papers citing papers by Katherine Ruzhansky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Ruzhansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Ruzhansky. The network helps show where Katherine Ruzhansky may publish in the future.

Co-authorship network of co-authors of Katherine Ruzhansky

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Ruzhansky. A scholar is included among the top collaborators of Katherine Ruzhansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Ruzhansky. Katherine Ruzhansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Ruzhansky, Katherine, Yuebing Li, Gil I. Wolfe, et al.. (2025). Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice: A Report of the MGFA Task Force. Muscle & Nerve. 72(1). 56–65. 1 indexed citations

Brandsema, John F., Hideki Hoshino, Masakazu Mimaki, et al.. (2024). Eculizumab in Adolescent Patients With Refractory Generalized Myasthenia Gravis: A Phase 3, Open-Label, Multicenter Study. Pediatric Neurology. 156. 198–207. 7 indexed citations

Boroojerdi, Babak, et al.. (2024). Usability of the zilucoplan prefilled syringe for the treatment of generalized myasthenia gravis: insights from a human factors validation study. Expert Review of Medical Devices. 21(10). 977–982.

Guptill, Jeffrey T., Michael Benatar, Volkan Granit, et al.. (2023). Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials. Neurology. 101(10). 442–451. 15 indexed citations

Brandsema, John F., Hideki Hoshino, Masakazu Mimaki, et al.. (2023). A Phase 3, Open-Label, Multicenter Study To Evaluate Eculizumab In Adolescents With Refractory Generalized Myasthenia Gravis (S5.009). Neurology. 100(17_supplement_2). 3 indexed citations

Hehir, Michael K., Mark R. Conaway, Eric M. Clark, et al.. (2022). The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events. PLoS ONE. 17(2). e0262109–e0262109. 4 indexed citations

Ruzhansky, Katherine, Neelam Goyal, Suraj Muley, & Tuan Vu. (2022). Treatment Burden According to Patients with Generalized Myasthenia Gravis (P6-13.008). Neurology. 98(18_supplement). 1 indexed citations

Guidon, Amanda C., Srikanth Muppidi, Richard J. Nowak, et al.. (2021). Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG‐CE). Muscle & Nerve. 64(3). 270–276. 21 indexed citations

Hehir, Michael K., Lisa D. Hobson‐Webb, Michael Benatar, et al.. (2017). Rituximab as treatment for anti-MuSK myasthenia gravis. Neurology. 89(10). 1069–1077. 166 indexed citations

10.

Ruzhansky, Katherine & Thomas H. Brannagan. (2015). Neuromuscular complications of hematopoietic stem cell transplantation. Muscle & Nerve. 52(4). 480–487. 12 indexed citations

11.

Traub, Rebecca, et al.. (2015). Causes of neuropathy in patients referred as “idiopathic neuropathy”. Muscle & Nerve. 53(6). 856–861. 59 indexed citations

12.

Ruzhansky, Katherine, et al.. (2014). Discordant Phenotype in Monozygotic Female Twins With Lys35Thr TTR Familial Amyloidotic Polyneuropathy. Journal of Clinical Neuromuscular Disease. 16(1). 1–6. 4 indexed citations

13.

Ruzhansky, Katherine & Thomas H. Brannagan. (2013). Intravenous immunoglobulin for treatment of neuromuscular disease. Neurology Clinical Practice. 3(5). 440–445. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact